Report type: Weekly Strategy
From Summer to Autumn – What Will Happen to Japanese Stocks During the Oct-Dec Period?
The Japanese stock market for the week of 24/9 was buoyed by reaction buying when the Nikkei Average dipped below 22,000 points on 25/9, in the midst of buying activities as the final day of dividend rights, 26/9, approached. However, on 27/9, the ex-rights date, the Nikkei Average dropped to the 21,700 points level, which is lower than the ex-dividend amount. As a result of active trading, the Nikkei Average began to rise after 5/9 and exceeded 22,000 points in a short period. The market was therefore perhaps timing for a “healthy dip”. Buying demand through rights acquisition is expected to subside, but the market is expected to be supported by reinvestment purchases and the consumption of NISA’s tax-exempt amount of 1.2 million yen per year.
The US-Japan Summit was held on 25/9, with confirmation of a final agreement on the US-Japan trade agreement. It will be good news for the automobile industry, which is positioned as the mainstay of Japan’s export industry, as it is expected to avoid additional vehicle tariffs. In addition, reductions in tariffs on US beef, pork, wine, etc., will benefit Japanese consumers who are preparing for the increase in consumption tax, and have the effect of supporting personal consumption within the Japanese economy.
The Japanese stock market is currently strong, but the following risks might arise during the Oct-Dec quarter. Firstly, the Democratic Party’s promising candidates are being narrowed down ahead of the US presidential election a year later in 2020. In particular, Senator Warren is known to be anti-Wall Street, and has been actively pushing for the breakup of “GAFA” companies which are representative US stocks. She can therefore be a strong adversary not only for President Trump, but also for the stock market. In addition, steps are being taken to reduce credit lines for Softbank Group’s (9984) Vision Fund in connection with the postponement of US We Company’s IPO. In this regard, the market has begun to scrutinize this IPO closely, and there is concern about the company’s stock price, which is a major contributor to the Nikkei Average. On the other hand, depending on the additional monetary easing measures to be adopted by the BOJ, there may be a shift to high dividend yield and low PBR stocks with lower risks on dividend reductions, along with debates on account maintenance fees for bank deposits.
Recent activities are mainly game-related. As a smartphone location game, “Dragon Quest Walk” is becoming a hit since “Pokemon GO”. Nintendo Switch’s “Ring Fit Adventure”, scheduled to be released on 18/10, is expected to surpass Wii-Fit, the previous hit product. Furthermore, it should also be noted that interest in “Item Assets” in “Blockchain Games” related to crypto assets has also been increasing.
In the 30/9 issue, we will be covering Oisix ra daichi (3182), Fujifilm Holdings (4901), Nippon Steel Trading (9810), Bengo4.com (6027), Geechs (7060) and Fancl (4921).
・Established in 1997. Receives orders through websites and catalogs, and develops business delivering food (vegetables, processed foods, and meal kits), daily necessities and miscellaneous goods. Has a Solutions Business catering to the food EC business sector, and a Store Business developing a dedicated “Shop in Shop” concept at its own stores and supermarkets in other companies.
・For 1Q (Apr-June) results of FY2020/3 announced on 13/8, net sales decreased by 3.5% to 16.265 billion yen compared to the same period the previous year, operating income decreased by 11.0% to 543 million yen, and net income decreased by 49.7% to 270 million yen. Due to a change in the accounting period, results were impacted by the recording of four months of the results of “Radish Boya” business in the same period the previous year. Amortization of goodwill of Welcome has also impacted results.
・For its full year plan, net sales is expected to increase by 9.3% to 70.0 billion yen compared to the previous year, operating income to decrease by 4.9% to 2.2 billion yen, and current income to decrease by 58.1% to 1.0 billion yen. Company’s meal kits have been gaining support mainly from child-raising families because it can produce multiple items in 10-20 minutes. As a result of the impending consumption tax hike, company may capture households curbing eating outs.
・Established in 1934 when Dainippon Celluloid’s (current Daicel) photographic film business was separated. A holding company with Fuji Film and Fuji Xerox under its umbrella. Developing the Imaging Solutions, Healthcare & Material Solutions and Document Solutions businesses based on fundamental technologies cultivated through its silver halide photography knowhow.
・For 1Q (Apr-June) results of FY2020/3 announced on 8/8, net sales decreased by 5.2% to 535.326 billion yen compared to the same period the previous year, operating income increased by 0.7% to 37.113 billion yen, and net income decreased by 48.2% to 14.662 billion yen. Medical systems and regenerative medicine sector grew, and the profitability of the Document Solutions business had improved. Net income decreased due to loss on valuation of equity securities.
・For its full year plan, net sales is expected to increase by 2.0% to 2.48 trillion yen compared to the previous year, operating income to increase by 14.4% to 240.0 billion yen, and current income to increase by 12.2% to 155.0 billion yen. Company announced on 26/9 that it would start a contract development and manufacturing service for peptides that support pharmaceutical research and development in response to increasing functionality and purity of peptides.
Important Information
This report is prepared and/or distributed by Phillip Securities Research Pte Ltd ("Phillip Securities Research"), which is a holder of a financial adviser’s licence under the Financial Advisers Act, Chapter 110 in Singapore.
By receiving or reading this report, you agree to be bound by the terms and limitations set out below. Any failure to comply with these terms and limitations may constitute a violation of law. This report has been provided to you for personal use only and shall not be reproduced, distributed or published by you in whole or in part, for any purpose. If you have received this report by mistake, please delete or destroy it, and notify the sender immediately.
The information and any analysis, forecasts, projections, expectations and opinions (collectively, the “Research”) contained in this report has been obtained from public sources which Phillip Securities Research believes to be reliable. However, Phillip Securities Research does not make any representation or warranty, express or implied that such information or Research is accurate, complete or appropriate or should be relied upon as such. Any such information or Research contained in this report is subject to change, and Phillip Securities Research shall not have any responsibility to maintain or update the information or Research made available or to supply any corrections, updates or releases in connection therewith.
Any opinions, forecasts, assumptions, estimates, valuations and prices contained in this report are as of the date indicated and are subject to change at any time without prior notice. Past performance of any product referred to in this report is not indicative of future results.
This report does not constitute, and should not be used as a substitute for, tax, legal or investment advice. This report should not be relied upon exclusively or as authoritative, without further being subject to the recipient’s own independent verification and exercise of judgment. The fact that this report has been made available constitutes neither a recommendation to enter into a particular transaction, nor a representation that any product described in this report is suitable or appropriate for the recipient. Recipients should be aware that many of the products, which may be described in this report involve significant risks and may not be suitable for all investors, and that any decision to enter into transactions involving such products should not be made, unless all such risks are understood and an independent determination has been made that such transactions would be appropriate. Any discussion of the risks contained herein with respect to any product should not be considered to be a disclosure of all risks or a complete discussion of such risks.
Nothing in this report shall be construed to be an offer or solicitation for the purchase or sale of any product. Any decision to purchase any product mentioned in this report should take into account existing public information, including any registered prospectus in respect of such product.
Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may provide an array of financial services to a large number of corporations in Singapore and worldwide, including but not limited to commercial / investment banking activities (including sponsorship, financial advisory or underwriting activities), brokerage or securities trading activities. Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may have participated in or invested in transactions with the issuer(s) of the securities mentioned in this report, and may have performed services for or solicited business from such issuers. Additionally, Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may have provided advice or investment services to such companies and investments or related investments, as may be mentioned in this report.
Phillip Securities Research or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report may, from time to time maintain a long or short position in securities referred to herein, or in related futures or options, purchase or sell, make a market in, or engage in any other transaction involving such securities, and earn brokerage or other compensation in respect of the foregoing. Investments will be denominated in various currencies including US dollars and Euro and thus will be subject to any fluctuation in exchange rates between US dollars and Euro or foreign currencies and the currency of your own jurisdiction. Such fluctuations may have an adverse effect on the value, price or income return of the investment.
To the extent permitted by law, Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may at any time engage in any of the above activities as set out above or otherwise hold an interest, whether material or not, in respect of companies and investments or related investments, which may be mentioned in this report. Accordingly, information may be available to Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, which is not reflected in this report, and Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may, to the extent permitted by law, have acted upon or used the information prior to or immediately following its publication. Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited its officers, directors, employees or persons involved in the issuance of this report, may have issued other material that is inconsistent with, or reach different conclusions from, the contents of this report.
The information, tools and material presented herein are not directed, intended for distribution to or use by, any person or entity in any jurisdiction or country where such distribution, publication, availability or use would be contrary to the applicable law or regulation or which would subject Phillip Securities Research to any registration or licensing or other requirement, or penalty for contravention of such requirements within such jurisdiction.
This report is intended for general circulation only and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. The products mentioned in this report may not be suitable for all investors and a person receiving or reading this report should seek advice from a professional and financial adviser regarding the legal, business, financial, tax and other aspects including the suitability of such products, taking into account the specific investment objectives, financial situation or particular needs of that person, before making a commitment to invest in any of such products.
This report is not intended for distribution, publication to or use by any person in any jurisdiction outside of Singapore or any other jurisdiction as Phillip Securities Research may determine in its absolute discretion.
IMPORTANT DISCLOSURES FOR INCLUDED RESEARCH ANALYSES OR REPORTS OF FOREIGN RESEARCH HOUSE
Where the report contains research analyses or reports from a foreign research house, please note:
